Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.12 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.08 | 0.7 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.071 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.071 | 0.7 |